Table 1.
Baseline Characteristics of Patients Assessed with DASS/HADS and MOS-HIV Questionnaires
| HADS / DASS (N=251) | MOS-HIV (N=241) | |||||
|---|---|---|---|---|---|---|
| CT Arm N=76 | STI Arm N=175 | p-Value | CT Arm N=82 | STI Arm N=159 | p-Value | |
| Male gender (%) | 25 (32.9) | 77 (44.0) | 0.10 | 50 (61.0) | 79 (49.7) | 0.10 |
| Route of HIV infection (%) | 0.33 | 0.56 | ||||
| Heterosexual | 67 (88.2) | 154 (88.0) | 72 (87.8) | 131 (82.4) | ||
| MSM | 7 (9.2) | 18 (10.3) | 9 (11.0) | 25 (15.7) | ||
| IVDU | 1 (1.3) | 0 | 1 (1.2) | 0 | ||
| Naïve patient (%) | 52 (68.4) | 115 (65.7) | 0.63 | 50 (61.0) | 93 (58.5) | 0.71 |
| Mean duration of HIV, months (±SD) | 31.9 (±24.1) | 33.1 (±28.6) | 0.76** | 30.2 (±20.9) | 35.4 (±30.1) | 0.66** |
| Age, years (±SD) | 35.5 (±8.1) | 35.4 (±8.0) | 0.91* | 36.6 (±7.6) | 35.3 (±7.7) | 0.22* |
| CD4 count, cells/mm3 (±SD) | 254 (±113) | 265 (±88) | 0.46** | 491 (±120) | 491 (±150) | 0.98* |
| Viral load, log10 cp/mL (±SD) | 4.7 (±0.7) | 4.68 (±0.7) | 0.88** | 4.7 (±0.7) | 4.7 (±0.6) | 0.90 |
| Number of STI cycles (%) | - | |||||
| 1 | 72 (41.1) | 62 (39.0) | ||||
| 2 | 65 (37.1) | 51 (32.1) | ||||
| >=3 | 38 (21.7) | 46 (28.9) | ||||
| N° who answered questionnaire (%) | ||||||
| Baseline | 76 (100) | 175 (100) | - | 82 (100) | 159 (100) | - |
| Week 24 | 60 (78.9) | 145 (82.9) | 0.46 | 69 (84.1) | 129 (81.1) | 0.56 |
| Week 48 | 53 (69.7) | 111 (63.4) | 0.33 | 60 (73.2) | 120 (75.5) | 0.70 |
| Last time-point visit | 65 (85.5) | 142 (81.1) | 0.40 | 46 (56.1) | 87 (54.7) | 0.84 |
| Mean participation, months (±SD) | 14.5 (±5.6) | 14.4 (±5.9) | 0.91** | 18.1 (±7.5) | 16.9 (±6.9) | 0.21 |
*
Mann-Whitney test because equality of variance not assumed.
**
Student-t test.